Cell Therapy Facility Design: discussing Autologous vs. Allogeneic and the principles of adaptive design. In this presentation, experts in cell therapy facility design from PM Group, Tyler Underhill PE and Daryl Kern, AIA will discuss the differences between autologous and allogeneic cell therapy and principles of adaptive design. This presentation is best suited for the pharmaceutical professional that would like to broaden their understanding of cell therapy facility design.
In-person attendance is encouraged, but there will also be a virtual option to attend this program.
Attendees are eligible to earn 1.0 PDH credit for this program.
5:00 - 6:00 PM - Networking (Cash Bar)
6:00 - 6:30 PM - Buffet Dinner
6:30 - 8:00 PM - Presentations
Tyler Underhill is a Senior Director of Biologics and Cell/Gene Therapies at PM Group, Boston Office. He is an accomplished Process Engineer with more than 10 years of experience in the pharmaceutical and biopharmaceutical industries.
Daryl Kern is Director of Architecture / Principal Architect at PM Group's Philadelphia Office. Daryl leads PM Group's Philadelphia architecture department with more than 10 years of experience in his field.
Registration will open at 5:00pm and a buffet dinner will be served at 5:30pm, followed by the presentations. One complimentary drink ticket will be provided, followed by a cash bar.
The program will conclude at 8:00pm.
DoubleTree suites by Hilton, Philadelphia West
640 Fountain Road, Plymouth Meeting, PA 19462